COMMUNIQUÉS West-GlobeNewswire

Scholar Rock Announces Appointment of George Nomikos, M.D., Ph.D., as Vice President, Head of Medical Research, Muscle Franchise
05/09/2019
Highly experienced physician-scientist and drug developer to lead SRK-015 latent myostatin program CAMBRIDGE, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage [...]
Solid Biosciences Announces Publication Highlighting the Important Role of the nNOS Domain in Microdystrophin Function and its Potential Utility in DMD Gene Therapy in the Journal Neuromuscular Disorders
05/09/2019
CAMBRIDGE, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) today announced the publication of a review article in the journal Neuromuscular Disorders ¹ that summarizes the evidence [...]
Stemline Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference
05/09/2019
NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, [...]
New Caregiver-Reported Data Further Validate the Use of the Aberrant Behavior Checklist Community: FXS Specific (ABC-CFXS) Subscales to Assess Core Behavioral Symptoms of Fragile X Syndrome (FXS)
05/09/2019
- Ninety Percent of Interviewed Caregivers Reported Social Avoidant, Irritability, and Socially Lethargic Behaviors in their Children with FXS - - New Data Presented Today at the Society for the Study of Behavioural [...]
Autism Spectrum Disorder, Fragile X Syndrome, and 22q11.2 Deletion Syndrome Share a Constellation of Sociobehavioral Symptoms
05/09/2019
- Preliminary Evidence Shows that CBD May Prove to be Effective in Managing the Spectrum of Behavioral Symptoms Associated with these Conditions – - New Data Presented Today at the Society for the Study of Behavioural [...]
Summit Presented In Vivo Proof of Concept Data for Targeted Enterobacteriaceae Antibiotics at ASM/ESCMID Conference
05/09/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Presents In Vivo Proof of Concept Data for Targeted Enterobacteriaceae Antibiotic at ASM/ESCMID Conference New Mechanism Antibiotic has Potential to Overcome [...]
Zafgen to Explore Strategic Alternatives
05/09/2019
Preliminary results from in vivo animal study not expected to warrant near-term resolution of clinical hold for ZGN-1061 BOSTON, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage [...]
Unum Therapeutics to Present at Upcoming Industry Conferences in September
05/09/2019
CAMBRIDGE, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on developing curative cell therapies for cancer, today announced its [...]
Microbix Quality Products Attain European Registration
05/09/2019
Four IVD Controls to Support Performance of Human Papilloma Virus (HPV) Tests MISSISSAUGA, Ontario, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products [...]
Trillium Therapeutics To Present At Investor Conference
05/09/2019
TORONTO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced today that the [...]
Anavex Life Sciences to Present at the Janney Healthcare Conference 2019
05/09/2019
NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]
Axsome Therapeutics Presents Positive AXS-07 Phase 1 Trial Results at the 19th Congress of the International Headache Society
05/09/2019
Dual mechanisms, rapid absorption and long half-life support therapeutic potential of AXS-07 in migraine AXS-07 MOMENTUM Phase 3 trial ongoing in migraine patients with history of inadequate response to prior acute [...]
Nabriva Therapeutics to Present Data at ASM/ESCMID Conference Demonstrating Utility of Xenleta™ (lefamulin) for Patients with Community-Acquired Bacterial Pneumonia (CABP)
05/09/2019
DUBLIN, Ireland, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat [...]
Novan and Aspire Capital Enter into a Common Stock Purchase Agreement for up to $25 Million
05/09/2019
MORRISVILLE, N.C., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company has entered into a Common Stock Purchase Agreement (the “Agreement”) of up to $ [...]
Philips’ intelligent health solutions at IFA 2019 adapt to individual consumer needs
05/09/2019
September 5, 2019 Easy, perfectly cooked homemade dishes using the Philips Airfryer with Smart Sensing technology, which automatically adjusts time and temperature Shaving without skin irritation with the AI-powered [...]
Livongo Reports Second Quarter Financial Results
05/09/2019
Second quarter Total Revenue of $40.9 million, up 156% year-over-year 192,934 enrolled Livongo for Diabetes Members, up 140% year-over-year with 38,170 new Livongo for Diabetes Members in Q2 MOUNTAIN VIEW, Calif., Sept [...]
Successful Pollen Season Confirms ASIT biotech On Track for Phase III Results of gp-ASIT+™ in December 2019
05/09/2019
• End of pollen season reached in all sites, allowing for last subject visits according to plan • Vaccine industry veteran Beatrice De Vos, MD, to join ASIT biotech as Chief Medical Officer • New CMO to focus on gp-ASIT [...]
AgraFlora Organics Awarded YuShop Global Listing; To Fulfill Chinese Pre-Orders with Premium Hemp-Derived Cosmetics SKUs Via One of China’s Premier Cross-Border Lifestyle/E-Commerce Platform
05/09/2019
VANCOUVER, British Columbia, Sept. 05, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF ), a growth oriented and diversified [...]
Zealand Pharma announces private placement and directed issue of new shares with expected gross proceeds of DKK 559.6 million
05/09/2019
Company announcement – No. 30 / 2019 A total of 3,975,000 new shares (the "New Shares") have been subscribed for with expected gross proceeds of approx. DKK 559.6 million The private placement and directed share issue [...]

Pages